rohan jain

[rohan jain @madmax3898]

@LaLigaMichael Olmo not in catalunya?

[rohan jain @madmax3898]

@amitabhvatsya hi sir, are we entering Neetu Yoshi? Your views on today’s concall

[rohan jain @madmax3898]

@ShivSha7 @Rahulsingh36167 any views on Neetu yoshi?

[rohan jain @madmax3898]

@SunejaTechnical It did not? What can we expect next?

[rohan jain @madmax3898]

@_PSG123 they have clauses in their contracts which passes on the increase in RM prices to their customers
The plant which is running right now is at at around 60% - so they have enough capacity till 250 cr revenue
The new plant will get the capacity to around 800cr revenue

[rohan jain @madmax3898]

@Abhi4Research Chandan healthcare and Neetu yoshi ⭐️⭐️

[rohan jain @madmax3898]

@sudheep8531 is neetu yoshi still good to add, or should we wait for retraction
and about Chandan healthcare forward PE -12
any views?

[rohan jain @madmax3898]

@ShridhantS @GingerInvest44 For which company, Neetu yoshi?

[rohan jain @madmax3898]

@ReshadRahman Link pls

[rohan jain @madmax3898]

@sudheep8531 Chandan healthcare seems to be undervalued
Good earnings and even better concall

[rohan jain @madmax3898]

@aditya942000 Super concall
Expecting minimum growth of 50% - conservative
Realistic numbers can be 80-100%
Delivering before time - 1000 franchises before the year end - previous target was in 3 years
Re rating soon 🔥🔥

[Fabrizio Romano @FabrizioRomano]

🚨🔵🔴 EXCLUSIVE: RODRI TO BARCELONA, HERE WE GO! 💥

Deal agreed for Spanish midfielder to join Barça from Man City, all done for the former Ballon d’Or.

Green light from Man City to last Barcelona bid.

More follows. 💣

[rohan jain @madmax3898]

@RajStockWatch The contribution to PAT is less than 2%, so not a impact, they can use the 60cr working capital more judiciously into the high margin diagnostic business?
Concall will give us a clear picture

[rohan jain @madmax3898]

@RajStockWatch Hi sir, your views on Chandan healthcare results?
Rerating soon?

[rohan jain @madmax3898]

@sachprat07 Pharmacy was pretty low margin business, margins will increase, volume will go down but ebitda margins and PAT will grow moving forward
Re-rating possible?
as the valuations were decent as well?

[rohan jain @madmax3898]

@sachprat07 Hi sir views on Chandan healthcare results please

[rohan jain @madmax3898]

@RajStockWatch V good results - Chandan health care
Your views on the results please?

[rohan jain @madmax3898]

@CuriousValueInv @aditya942000 They are settled with dayal institute

[rohan jain @madmax3898]

@iitgnitin Plus the sector PE is around 40-50, bullish times ahead!

[rohan jain @madmax3898]

@iitgnitin Pharmacy disinvestment is good for business - v low margin business - they can put in more resources and time in the diagnostic business
PE ratio dropping to around 17
V v cheap valuations
And if commentary is aggressive and positive, it can easily be a 4 digit stock soon